Skip to main content
SpringerLink
Log in

Recent depression updates: Relevant presentations

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

This review discusses several depression-relevant abstracts of posters and talks presented at the 2005 American College of Neuropsychopharmacology Annual Meeting and the 2006 Collegium Internationale Neuro-Psychopharmacologicum Meeting. Described are several novel psychopharmacologic treatments for major depressive disorder, some predictors of efficacy, and information relevant to understanding the activation of the hypothalamicpituitary-adrenal axis in depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Zarate C, Jaskaran S, Carlson P, et al.: Robust, rapid and relatively sustained antidepressant effects with a single-dose of an NMDA antagonist in treatment-resistant major depression: a double-blind placebo-controlled study [abstract]. Neuropsychopharmacology 2005, 30(Suppl 1):S245.

    Google Scholar 

  2. Furey M, Drevets W: The old drug scopolamine offers new promise as a potent antidepressant agent: a randomized, placebo-controlled clinical trial [abstract]. Neuropsychopharmacology 2005, 30(Suppl 1):S170.

    Google Scholar 

  3. Rybakowski M, Tuszewska P: Lithium or lamotrigine augmentation in the treatment-resistant depression [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S232.

    Google Scholar 

  4. Blier P, Ward P, Tremblay P, et al.: Serotonin-norepinephrine interactions in the antidepressant response: electrophysiological and clinical results [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S86.

    Google Scholar 

  5. Trivedi M, Grannemann J, Musgnung J, et al.: Employing symptom improvement patterns to predict remission in depressed outpatients treated with venlafaxine extended release (XR) or selective serotonin reuptake inhibitors [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S183.

    Google Scholar 

  6. Szegedi A, Jansen WT, Van Willigenburg AP: Early improvement as a predictor of individual treatment outcome with antidepressants: why the first 2 weeks really matter [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S255.

    Google Scholar 

  7. Tyrka AR, Carpenter L, Anderson G, et al.: Inhibited temperament and HPA axis function in healthy adults [abstract]. Neuropsychopharmacology 2005, 30(Suppl 1):S242.

    Google Scholar 

  8. Mannie Z, Cowen P, Harmer C: Increased cortisol levels in young people at high risk of depression [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S173.

    Google Scholar 

  9. Chopra K, Ravindran A, Bagby M, et al.: Neuroticism medicates cortisol stress responses to the Trier social stress test in chronic depression [abstract]. Int J Neuropsychopharmacol 2006, 9(Suppl 1):S188.

    Google Scholar 

  10. Young EA, Brown MB, Ribeiro S: Evidence of increased CRH pulsatility in major depression [abstract]. Neuropsychopharmacology 2005, 30(Suppl 1):S245.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of North Carolina School of Medicine, CB# 7175, 27599-7175, Chapel Hill, NC, USA

    David S. Janowsky MD

Authors
  1. David S. Janowsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David S. Janowsky MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janowsky, D.S. Recent depression updates: Relevant presentations. Curr Psychiatry Rep 8, 470–472 (2006). https://doi.org/10.1007/s11920-006-0053-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-006-0053-8

Keywords

Search

Navigation